Imaging Biomarker Market By Imaging Technology( CT, PET, MRI, US, SPECT), By Product Type(Hormones, Enzymes, Antibodies, Gene products), By Therapeutic Areas(Oncology, Cardiology, Immunology, Neurology), By Application(Drug Discovery, Disease Diagnosis, Genetic Studies, Molecular Diagnostics, Bioinformatics), By End-User

Imaging Biomarkers Market in the Global Industry Landscape

Imaging biomarker market is swiftly growing with the advancement in technologies and research & development in the field of disease diagnosis and drug discovery. Biomarker indicates the risk of any disease in any part of the body and with the use of imaging technology biomarkers reveals the exact site of the possible disease even in their early stage. The global fight against cancer management is leading the application of imaging biomarker. Increasing number of hospitals, toxicity profiling cases and targeted drug discovery are driving the growth of the market.

Further, imaging biomarker has led to a trend of ‘precision medicine’ wherein the tailored treatment is available to the individual patient. Such as in oncology, multiple layers of patient data is considered while treating a patient which includes family history, demographics, tissue, and blood markers. The information is used for disease screening, prognosis, differential diagnosis, and prediction of treatment in terms of response or recurrence. Furthermore, the use of imaging biomarkers in clinical trials has led to the development of new drugs and operational efficiencies, that hasn’t been fully realized yet. Also, the reading, homogenizing and easing radiological conclusion facilitates the clinical trials conducted by the companies.

Our Global Imaging Biomarkers Market can be segmented on the following basis:

By Imaging Technology

• Computed Tomography (CT)
• Positron Emission Tomography (PET)
• Magnetic Resonance Imaging (MRI)
• Ultrasound (US)
• Single Photon Emission Computed Tomography (SPECT)

By Product Type

• Hormones
• Enzymes
• Antibodies
• Gene products

By Therapeutic Areas

• Oncology
• Cardiology
• Immunology
• Neurology
• Others (Hematology, Biochemistry, etc.)

By Application

• Drug Discovery and Development
• Disease Diagnosis
• Genetic Studies
• Molecular Diagnostics
• Bioinformatics
• Others (Forensic Application, etc.)

By End-User

• Pharmaceutical Companies
• Hospitals
• Research Labs and Institutes
• Contract Research Organizations (CROs)

By Geography

• North America (U.S. & Canada)  Imaging Biomarkers Market {Market Share (%), Market Size (USD Billion)}
• Latin America (Brazil, Mexico, Argentina & Rest Of Latin America) Imaging Biomarkers Market {Market Share (%), Market Size (USD Billion)}
• Europe (The U.K., Germany, France, Italy, Hungary, Spain, Poland, Sweden & Roe)  Imaging Biomarkers Market {Market Share (%), Market Size (USD Billion)}
• Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest Of Asia)  Imaging Biomarkers Market {Market Share (%), Market Size (USD Billion)}
• Middle East & Africa (GCC, South Africa, North Africa, Romea) Imaging Biomarkers Market {Market Share (%), Market Size (USD Billion)}

Global Imaging Biomarkers Market Outlook comprises of the following data:

• Global Imaging Biomarkers Market by Value, Volume and Average Selling Price, 2017-2025
• Coverage Numbers and Type of Imaging Biomarkers in Clinical Use, 2016-2017
• Number of People Diagnosed with Diseases at Primary Stage, 2017-2025
• New Entrants in the Global Imaging Market, 2016-2017
• Patent Application and Grant in Imaging Biomarker (USD), 2017-2025
• Global Imaging Biomarkers Market by Distributor Analysis (USD), 2016-2017

In 2016 on the basis of imaging technology, MRI segmented accounted for the largest market share of the total imaging biomarker market. The MRI technology uses a magnetic field and is also safer to use as compared to other technologies, thus leading to higher attraction from the service providers such as hospitals. Further, CT technology is able take more images in a short period of time. Therefore, in the near future CT technology is expected to be touching heights in the overall market.

Regardless of the obvious value of imaging, imaging biomarkers undertrials are facing few challenges, such as the lack of standardization throughout the multivendor platforms, the complexity of imaging techniques, and lack of improved trial design and operational support.

In November 2017, Bioclinica, the global leading provider of Medical Imaging, eHealth, and patient-centric solutions had acquired MDDX Research & Informatics, having one of the most advanced cloud research image management and submission technologies to effectively, accurately and reliably manage the clinical trials in terms of critical medical imaging.

Expert Analysis: Imaging biomarkers are successfully in use over a past decade. Large number of imaging biomarkers are used for the purpose of drug discovery and eliminating diseases from the root cause. Yet imaging biomarkers market has to unbind the numerous possibilities based on the stage of drug discovery with the support of advancing technologies.

For a full detailed overview, send us the sample request.

Key questions answered in this Global Imaging Biomarker Market Report

• What is the total market size by 2025 and what would be the expected growth rate of the market?
• What is the total revenue per segment and region in 2015-16 and what would be the expected revenue per segment and region over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry-level players?
• What are the recent developments and business strategy of the key players?

Reasons to buy this market study

• Facilitate decision-making based on strong historic and forecast data for global Imaging Biomarker Market
• Develop strategies based on the latest regulatory framework
• Position yourself to gain the maximum advantage of the global Imaging Biomarker market’s growth potential
• Identify key partners and business development avenues across the globe
• Respond to your competitors’ business structure, strategy and prospects